Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2014)
Catalyst Pharmaceuticals (CPRX) recorded Interest & Investment Income of $5,924 in Q3 2014, down 42.6% from $10,318 a year earlier and down 62.4% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2014) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' Interest & Investment Income came in at $76,538 as of Sep 30, 2014, up 119.6% year-over-year; for FY2013, it was $47,421, up 216.6% from FY2012.
- Annual Interest & Investment Income has a four-year compound annual growth rate of 9.1% (FY2009 to FY2013).
- Across earlier years, Interest & Investment Income came in at $14,976 in FY2012 (+36.3%), $10,985 in FY2011 (-38.5%), $17,858 in FY2010 (-46.6%) and $33,466 in FY2009.
- The Q3 2014 figure is the lowest quarterly Interest & Investment Income since Q3 2012.
- On a year-over-year basis, Interest & Investment Income rose in seven of the last eight quarters, with growth averaging 258.9%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 524.6% in Q2 2013, against a decline of 58.8% in Q2 2012 at the low end.
- Per Business Quant, the preceding three quarters came in at $15,744 (Q2 2014), $32,760 (Q1 2014) and $22,110 (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 5,924.00 |
| Jun 30, 2014 | 15,744.00 |
| Mar 31, 2014 | 32,760.00 |
| Dec 31, 2013 | 22,110.00 |
| Sep 30, 2013 | 10,318.00 |
| Jun 30, 2013 | 8,526.00 |
| Mar 31, 2013 | 6,467.00 |
| Dec 31, 2012 | 9,550.00 |
| Sep 30, 2012 | 2,744.00 |
| Jun 30, 2012 | 1,365.00 |
| Mar 31, 2012 | 1,317.00 |
| Dec 31, 2011 | 2,390.00 |
| Sep 30, 2011 | 3,169.00 |
| Jun 30, 2011 | 3,312.00 |
| Mar 31, 2011 | 2,114.00 |
| Dec 31, 2010 | 3,418.00 |
| Sep 30, 2010 | 4,480.00 |
API Access
Catalyst Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();